Roll Call: IN SB0141 | 2019 | Regular Session
For additional roll call votes on Indiana SB0141 please see the Vote List
Bill Title: Office based opioid treatment providers. Specifies requirements that a health care provider that prescribes for a patient in an office based opioid treatment setting must meet in the treatment of the patient. Requires the medical licensing board of Indiana, in consultation with the state department of health and the office of the secretary of family and social services, to adopt rules or protocols concerning office based opioid treatment providers and: (1) treatment agreements; (2) periodic scheduled patient visits; (3) urine toxicology screenings; (4) HIV, hepatitis B, and hepatitis C testing; and (5) the medical record documentation required for the prescribing of buprenorphine over a specified dosage.
Spectrum: Slight Partisan Bill (Republican 6-2)
Status: (Passed) 2019-05-05 - Public Law 213 [SB0141 Detail]
Text: Latest bill text (Enrolled) [PDF]
Bill Title: Office based opioid treatment providers. Specifies requirements that a health care provider that prescribes for a patient in an office based opioid treatment setting must meet in the treatment of the patient. Requires the medical licensing board of Indiana, in consultation with the state department of health and the office of the secretary of family and social services, to adopt rules or protocols concerning office based opioid treatment providers and: (1) treatment agreements; (2) periodic scheduled patient visits; (3) urine toxicology screenings; (4) HIV, hepatitis B, and hepatitis C testing; and (5) the medical record documentation required for the prescribing of buprenorphine over a specified dosage.
Spectrum: Slight Partisan Bill (Republican 6-2)
Status: (Passed) 2019-05-05 - Public Law 213 [SB0141 Detail]
Text: Latest bill text (Enrolled) [PDF]
Vote: Third reading
| Vote | Tally | Democrat | Republican |
|---|---|---|---|
| Yea | 42 | 3 | 39 |
| Nay | 6 | 6 | - |
| Not Voting | - | - | - |
| Absent | 2 | 1 | 1 |
| TOTAL | 50 | 10 | 40 |
